On January 26, The New England Journal of Medicine published the paper, “Tobacco Product Use by Adults and Youth in the United States in 2013 and 14.” Information and access to the abstract are below.
PATH: More Than a Quarter of US Adults, Roughly 9 Percent US Youth Use Tobacco Initial data on adult and youth tobacco use from the Population Assessment on Tobacco and Health (PATH) Study, published in the New England Journal of Medicine, showed that more than a quarter of American adults were current users of tobacco in 2013-14 and roughly 9 percent of youth reported using tobacco in the past 30 days. Multiple product use was common among tobacco users, with cigarettes and e-cigarettes being the most common combination among both adult and youth tobacco users.
The PATH Study aims to assess and monitor patterns in tobacco use behavior and changes in attitudes toward tobacco products over time. As the PATH study progresses and longitudinal data are collected, the researchers expect to identify factors that are associated with quitting tobacco, switching among different tobacco products, and using multiple tobacco products, as well as the health implications of these different behaviors. Such information can help inform FDA’s regulatory actions related to tobacco products, as well as the broader scientific community.
You may access the Pubmed abstract here: Here
PATH: More Than a Quarter of US Adults, Roughly 9 Percent US Youth Use Tobacco Initial data on adult and youth tobacco use from the Population Assessment on Tobacco and Health (PATH) Study, published in the New England Journal of Medicine, showed that more than a quarter of American adults were current users of tobacco in 2013-14 and roughly 9 percent of youth reported using tobacco in the past 30 days. Multiple product use was common among tobacco users, with cigarettes and e-cigarettes being the most common combination among both adult and youth tobacco users.
The PATH Study aims to assess and monitor patterns in tobacco use behavior and changes in attitudes toward tobacco products over time. As the PATH study progresses and longitudinal data are collected, the researchers expect to identify factors that are associated with quitting tobacco, switching among different tobacco products, and using multiple tobacco products, as well as the health implications of these different behaviors. Such information can help inform FDA’s regulatory actions related to tobacco products, as well as the broader scientific community.
You may access the Pubmed abstract here: Here
on Fri, 01/27/2017 - 21:57 admin
